So Leo and Menon have 10s of millions of shares (I think in the 30M) range. Not sure about Bertolino, but I think in the single digit millions. For Leo and Menon, when the stock was at $4.90 they arguably had over $100M in value. Today, that value is down to about $3M. I have read posts at the swamp suggesting that they are scamming shareholders for the salaries they take currently, but based upon the potential in the pipeline and the value they had, it seems much more likely that they want the SP to be the wealth generator for them. If they make a deal for B-OM and B-IBD, they not only generate wealth due to SP, but they can continue to pursue other areas, including K. I know biotech is very risky and things don't always go the way we hope, but my theory is Leo and Art are working diligently to get a deal done....they have way more incentive than anyone else.
By the way, an acquaintence of mine who works at a BP told me several years ago that you should not invest in small, start-up biotechs that are one-trick ponies since failure for them is a death knell and a high percentage of drugs fail. I remember thinking at the time that IPIX had three indications and that at least one had a good chance of getting to PIII. Glad we are not a one-trick pony and 2 out of 3 indications (actually more with B platform) are still in play.
(5)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links